非處方連續血糖監測市場規模、佔有率和成長分析：按產品類型、連接方式、最終用戶、分銷管道和地區分類 - 產業預測，2026-2033 年

2024 年全球非處方 (OTC) 連續血糖監測市場價值為 17.4 億美元，預計到 2033 年將從 2025 年的 18.9 億美元成長至 36.6 億美元，預測期（2026-2033 年）的複合年成長率為 8.6%。

非處方（OTC）連續血糖監測（CGM）市場正迅速發展，其驅動力在於以患者為中心的醫療模式日益普及，患者需要即時獲取健康數據。這種轉變使得人們能夠根據即時血糖值和警報調整飲食、運動和用藥。市場放鬆管制催生了自費模式，使得雅培和德康等知名品牌能夠提供非處方版本的CGM產品，從而吸引精通科技的消費者。健康意識的增強以及感測器成本的下降，正推動CGM產品被更廣泛地接受，甚至包括非糖尿病族群。此外，人工智慧（AI）和物聯網（IoT）的融合，透過個人化洞察和無縫資料傳輸，提升了使用者體驗，進一步促進了CGM的普及。總體而言，創業投資和夥伴關係有望推動市場成長和創新。

全球非處方連續血糖監測市場成長要素

全球非處方（OTC）連續血糖監測市場正經歷顯著成長，這主要得益於醫療專業人員擴大將這些設備作為糖尿病管理的重要工具。這一趨勢源於改善血糖控制和最大限度減少糖尿病併發症的願望。市售設備的普及使患者能夠獨立監測血糖值，從而促進積極的自我護理，並提高糖尿病管理意識。製造商正積極回應這項需求，開發符合日常需求的便利易用型設計，進一步降低新用戶的使用門檻。因此，各個人群的需求持續成長。

全球非處方連續血糖監測市場面臨的限制因素

全球非處方（OTC）連續血糖監測市場面臨諸多限制因素，其中最主要的是這些設備的零售價格通常較高。高昂的價格使得許多潛在用戶難以負擔。這種經濟障礙導致消費者即使認知到此類監測設備的健康益處，也往往猶豫不決，尤其是在醫保覆蓋不到的地區。因此，對價格敏感的消費者傾向於選擇較便宜的替代品，或乾脆延後監測，導致市場滲透率降低。這種經濟障礙不僅縮小了目標市場的整體規模，也限制了製造商實現規模經濟的機會，而規模經濟本來可以促進未來的價格下降。

全球非處方連續血糖監測市場趨勢

全球非處方（OTC）連續血糖監測市場正經歷著向居家糖尿病管理的轉型。隨著消費者對可與智慧型手機無縫整合、隱藏易用且穿戴式的裝置的需求不斷成長，他們正逐漸獲得即時血糖值監測功能。這一趨勢推動了對提供個人化分析和訂閱服務的綜合健康管理平台的需求日益成長，同時也促進了人們對預防醫學和生活方式改善的重視。製造商正致力於提升感測器精度、延長佩戴時間和簡化用戶體驗等創新，最終增強血糖值監測解決方案的吸引力，並重新定義個人獨立管理糖尿病的方式。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球非處方連續血糖監測市場規模：依產品類型分類

• 穿戴式 CGM 系統
• CGM感測器
• 領導者行動應用解決方案

全球非處方連續血糖監測市場規模：以連接方式分類

• 藍牙相容
• 相容NFC

全球非處方連續血糖監測市場規模：依最終用戶分類

• 糖尿病患者
• 糖尿病前期患者
• 健康與保健領域的一般消費者

全球非處方連續血糖監測市場規模：按分銷管道分類

• 藥局
• 線上零售
• 專業零售店

全球非處方連續血糖監測市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Abbott Laboratories
• Dexcom, Inc.
• Medtronic plc
• F. Hoffmann-La Roche Ltd
• Ascensia Diabetes Care Holdings AG
• LifeScan, Inc.
• A. Menarini Diagnostics Srl
• Sinocare Inc.
• Ypsomed Holding AG
• B. Braun SE
• Terumo Corporation
• Nemaura Medical Inc.
• Biolinq Incorporated
• Know Labs, Inc.
• Afon Technology Ltd.
• GlucoTrack, Inc.
• PKvitality SA
• Hagar hf.
• Integrity Applications, Inc.
• Senseonics Holdings, Inc.

結論與建議

Global Otc Continuous Glucose Monitoring Market size was valued at USD 1.74 Billion in 2024 and is poised to grow from USD 1.89 Billion in 2025 to USD 3.66 Billion by 2033, growing at a CAGR of 8.6% during the forecast period (2026-2033).

The over-the-counter (OTC) continuous glucose monitoring (CGM) market is rapidly evolving, driven by a growing emphasis on patient-centric care that prioritizes immediate access to health data. This shift allows individuals to adjust their diet, exercise, and medication based on real-time glucose trends and alerts. Regulatory relaxations have enabled self-pay models, with major brands like Abbott and Dexcom offering OTC versions of their CGM products, appealing to tech-savvy consumers. The convergence of health-conscious trends and declining sensor costs encourages wider acceptance, including by those without diabetes. Furthermore, the integration of artificial intelligence and IoT enhances user experience through personalized insights and seamless data transfer, fostering broader adoption. Overall, venture capital investments and partnerships are likely to fuel market growth and innovation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Otc Continuous Glucose Monitoring market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Otc Continuous Glucose Monitoring Market Segments Analysis

Global otc continuous glucose monitoring market is segmented by product type, connectivity, end user, distribution channel and region. Based on product type, the market is segmented into Wearable CGM Systems, CGM Sensors and Reader & Mobile App Solutions. Based on connectivity, the market is segmented into Bluetooth Enabled and NFC Enabled. Based on end user, the market is segmented into Individuals with Diabetes, Prediabetic Individuals and Health & Wellness Consumers. Based on distribution channel, the market is segmented into Pharmacies, Online Retail and Specialty Retail Stores. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Otc Continuous Glucose Monitoring Market

The global market for over-the-counter continuous glucose monitoring is experiencing significant growth, largely due to the increasing adoption of these devices by healthcare providers as essential tools in diabetes management. This trend stems from a desire to enhance glycemic control and minimize complications associated with diabetes. The availability of over-the-counter devices empowers patients to independently monitor their glucose levels, promoting proactive self-care and fostering greater awareness of diabetes management. As manufacturers respond by creating user-friendly designs tailored to everyday needs, the convenience of these devices further lowers barriers for new users. Consequently, demand continues to expand across various demographic segments.

Restraints in the Global Otc Continuous Glucose Monitoring Market

The Global OTC Continuous Glucose Monitoring market faces a significant restraint due to the often high retail prices of these devices, which can be unaffordable for many potential users. This financial hurdle discourages consumers, especially in areas without insurance coverage, from investing in these monitors, even when they recognize their health advantages. As a result, market penetration suffers, as price-sensitive individuals tend to choose cheaper alternatives or postpone monitoring altogether. This economic obstacle not only shrinks the overall target demographic but also limits manufacturers' opportunities to achieve economies of scale, which could otherwise facilitate price reductions in the future.

Market Trends of the Global Otc Continuous Glucose Monitoring Market

The Global OTC Continuous Glucose Monitoring market is experiencing a transformative shift towards home-based diabetes management. With a growing preference for discreet, user-friendly wearable devices that integrate seamlessly with smartphone technology, consumers are empowered to monitor their glucose levels in real-time. This trend is fostering an increased demand for comprehensive health management platforms that offer personalized analytics and subscription services, aligning with a broader emphasis on preventive care and lifestyle changes. Manufacturers are innovating by improving sensor accuracy, extending wear duration, and simplifying user experiences, ultimately broadening the appeal of glucose monitoring solutions and redefining how individuals manage their diabetes independently.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global OTC Continuous Glucose Monitoring Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Wearable CGM Systems
• CGM Sensors
• Reader & Mobile App Solutions

Global OTC Continuous Glucose Monitoring Market Size by Connectivity & CAGR (2026-2033)

• Market Overview
• Bluetooth Enabled
• NFC Enabled

Global OTC Continuous Glucose Monitoring Market Size by End User & CAGR (2026-2033)

• Market Overview
• Individuals with Diabetes
• Prediabetic Individuals
• Health & Wellness Consumers

Global OTC Continuous Glucose Monitoring Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Pharmacies
• Online Retail
• Specialty Retail Stores

Global OTC Continuous Glucose Monitoring Market Size & CAGR (2026-2033)

• North America (Product Type, Connectivity, End User, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Connectivity, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Connectivity, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Connectivity, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Connectivity, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care Holdings AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeScan, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• A. Menarini Diagnostics S.r.l.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinocare Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nemaura Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biolinq Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Know Labs, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Afon Technology Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlucoTrack, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PKvitality SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hagar hf.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrity Applications, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Senseonics Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations